Regeneron

All the email addresses for regeneron.com

{first}.{last}@regeneron.com
152 email addresses
http://prnewswire.com/news-releases/regeneron-reports-first-quarter-2012-financial-and-operating-results-149024265.html January 1, 2015
http://prnewswire.com/news-releases/regeneron-reports-fourth-quarter-and-full-year-2012-financial-and-operating-results-191179371.html March 3, 2015
http://drugs.com/clinical_trials/sanofi-aventis-regeneron-report-positive-phase-iii-results-zaltrap-aflibercept-second-line-11621.html March 3, 2016
http://drugs.com/clinical_trials/positive-phase-2b-results-sarilumab-rheumatoid-arthritis-presented-late-breaking-poster-2011-12563.html April 4, 2015
http://de.sys-con.com/node/2534519 March 3, 2016
http://bio-medicine.org/medicine-technology-1/regeneron-announces-march-2011-investor-conference-presentations-14919-1 March 3, 2016
http://sanofi.de/l/de/de/layout.jsp August 8, 2015
http://prnewswire.com/news-releases/regeneron-announces-receipt-of-hart-scott-rodino-notice-190674041.html January 1, 2015
http://biospace.com/collaborative/News/regeneron-pharmaceuticals-inc-bayer-healthcare/242583 March 3, 2015
http://biospace.com/news_print.aspx May 5, 2015
http://thenumbers.marketplace.org/publicradio/news/read/23130453/regeneron_recommends_rejection_of_mini April 4, 2015
http://au.sys-con.com/node/2534519 January 1, 2015
http://newsroom.regeneron.com/releasedetail.cfm July 7, 2015
http://prnewswire.com/news-releases/regeneron-reports-third-quarter-2012-financial-and-operating-results-175567551.html January 1, 2015
http://bio-medicine.org/medicine-technology-1/regeneron-pharmaceuticals-announces-pricing-of-offering-of-convertible-senior-notes-due-october-1--2016-21180-1 March 3, 2016
http://drugs.com/clinical_trials/sanofi-regeneron-report-positive-phase-2b-trial-results-sarilumab-rheumatoid-arthritis-12112.html March 3, 2016
http://drugs.com/clinical_trials/sanofi-regeneron-report-phase-2-data-potential-first-class-lipid-lowering-pcsk9-antibody-13223.html May 5, 2017
http://thestreet.com/story/11331461/5/two-year-results-of-phase-3-studies-with-eylea-aflibercept-injection-in-wet-amd-show-sustained-improvement-in-visual-acuity.html January 1, 2015
http://biospace.com/collaborative/news/rockefeller-university-president-marc-tessier/241447 January 1, 2015
http://bio-medicine.org/medicine-technology-1/vegf-trap-eye-submitted-for-eu-marketing-authorization-for-treatment-of-wet-age-related-macular-degeneration-17903-1 March 3, 2016
http://br.sys-con.com/node/2534519 January 1, 2015
http://bio-medicine.org/medicine-technology-1/regeneron-to-report-fourth-quarter-and-full-year-2012-financial-and-operating-results-and-host-conference-call-and-webcast-on-february-14--2013-29934-1 March 3, 2016
http://drugs.com/clinical_trials/two-year-results-phase-3-studies-eylea-aflibercept-wet-amd-show-sustained-improvement-visual-acuity-12749.html March 3, 2016
http://biospace.com/news/regeneron-pharmaceuticals-inc-wins-fda-approval/241335 January 1, 2015
http://fiercebiotech.com/biotech/regeneron-announces-receipt-of-hart-scott-rodino-notice May 5, 2017
http://prnewswire.com/news-releases/regeneron-to-report-fourth-quarter-and-full-year-2012-financial-and-operating-results-and-host-conference-call-and-webcast-on-february-14-2013-188727991.html January 1, 2015
http://biospace.com/news/regeneron-pharmaceuticals-inc-announces-upcoming/287954/source=morenews January 1, 2015
http://investor.regeneron.com/releasedetail.cfm July 7, 2015
http://thestreet.com/story/11169001/2/eylea-aflibercept-injection-submitted-in-japan-for-marketing-authorization-for-the-treatment-of-wet-age-related-macular-degeneration.html March 3, 2016
http://clinicaspace.com/news/sanofi-france-says-zaltrap-approved-in-europe-for/286672/source=yesterdaysmostpopular January 1, 2015
http://einpresswire.com/article/404247521/sanofi-and-regeneron-announce-positive-study-results-for-dupixent-dupilumab-in-patients-with-moderate-to-severe-atopic-dermatitis October 10, 2017
http://holdthepresses.eu/2017/09/sanofi-and-regeneron-announce-positive.html October 10, 2017
http://mediaroom.sanofi.com/sanofi-and-regeneron-announce-positive-dupilumab-topline-results-from-two-phase-3-trials-in-inadequately-controlled-moderate-to-severe-atopic-dermatitis-patients May 5, 2017
http://benzinga.com/pressreleases/16/10/n8517612/regeneron-and-sanofi-announce-positive-dupixent-dupilumab-phase-3-atopi July 7, 2017
http://prnewswire.com/news-releases/new-survey-reveals-the-widespread-and-serious-impact-of-moderate-to-severe-atopic-dermatitis-on-people-living-with-the-disease-300339368.html August 8, 2017
http://pharmafocusasia.com/pressreleases/regeneron-announces-eu-approval-of-eylea-aflibercept-injection-for-the-treatment-of-visual-impairment-secondary-to-myopic-choroidal-neovascularization January 1, 2016
http://news.sanofigenzyme.com/print/node/3422 February 2, 2017
http://retinalinkglobal.com/regeneron-announces-important-us-prescribing-information-clarification-eylea-aflibercept-injection August 8, 2016
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-publication-positive-phase-2-dupilumab-data-journal-amer February 2, 2016
http://prnewswire.com/news-releases/sanofi-and-regeneron-to-present-new-data-on-dupixent-dupilumab-for-moderate-to-severe-atopic-dermatitis-at-upcoming-medical-congresses-300413658.html July 7, 2017
http://mediaroom.sanofi.com/sanofi-and-regeneron-announce-dupilumab-biologics-license-application-accepted-for-priority-review-by-u-s-fda May 5, 2017
http://life-sciences-france.com/news/sanofi-regeneron-ph3-results-euronext-san-nyse-sny-2001-107702.html June 6, 2016
http://biospace.com/news/sanofi-and-regeneron-receive-positive-chmp-opinion/463734 September 9, 2017
http://news.genzyme.com/print/node/3320 June 6, 2016
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-positive-dupilumab-topline-results-two-phase-3-trials-in June 6, 2016
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-dupilumab-used-topical-corticosteroids-tcs-was-superior- June 6, 2016
http://holdthepresses.eu September 9, 2017
http://life-sciences-europe.com/news/sanofi-regeneron-chmp-recommends-euronext-san-nyse-sny-2001-111062.html September 9, 2017
http://mediaroom.sanofi.com/sanofi-and-regeneron-announce-presentation-of-positive-data-from-long-term-pivotal-phase-3-chronos-study-of-dupixent-dupilumab-in-moderate-to-severe-atopic-dermatitis August 8, 2017
http://mediaroom.sanofi.com/sanofi-et-regeneron-obtiennent-un-avis-favorable-du-chmp-pour-dupixent-dupilumab-dans-le-traitement-de-la-dermatite-atopique-moderee-a-severe-de-ladulte September 9, 2017
http://careers.biospace.com/news/sanofi-and-regeneron-announce-fda-approval-of/450918 September 9, 2017
http://mediaroom.sanofi.com/sanofi-and-regeneron-announce-fda-approval-of-dupixent-dupilumab-the-first-targeted-biologic-therapy-for-adults-with-moderate-to-severe-atopic-dermatitis September 9, 2017
http://prnewswire.com/news-releases/new-survey-of-us-adults-with-diabetes-reveals-less-than-half-understand-their-risk-for-vision-loss-300172899.html September 9, 2017
http://prnewswire.com/news-releases/eylea-aflibercept-injection-receives-approval-in-japan-for-the-treatment-of-retinal-vein-occlusion-300105348.html May 5, 2017
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-announce-marketing-authorization-application-dupixent-dupilumab-a February 2, 2017
http://news.sanofigenzyme.com/press-release/new-survey-reveals-widespread-and-serious-impact-moderate-severe-atopic-dermatitis-peo February 2, 2017
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-announce-positive-dupixent-dupilumab-phase-3-atopic-dermatitis-da February 2, 2017
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-announce-dupilumab-biologics-license-application-accepted-priorit February 2, 2017
http://news.genzyme.com/print/node/3244 February 2, 2016
http://prnewswire.com/news-releases/new-survey-reveals-the-widespread-and-serious-impact-of-moderate-to-severe-atopic-dermatitis-on-people-living-with-the-disease-300339444.html July 7, 2017
http://prnewswire.com/news-releases/regeneron-genetics-center-and-geisinger-study-finds-life-threatening-genetic-disorder-is-substantially-underdiagnosed-300382688.html July 7, 2017
http://prweb.com/releases/2016/02/prweb13208560.htm May 5, 2017
http://mediaroom.sanofi.com/sanofi-et-regeneron-annoncent-le-lancement-dune-etude-de-phase-3-du-dupilumab-dans-le-traitement-de-la-dermatite-atopique-2 July 7, 2017
http://fiercepharma.com/vaccines/regeneron-joins-human-vaccines-project-to-improve-global-disease-prevention-and-treatment November 11, 2016
http://mediaroom.sanofi.com/sanofi-sanofi-and-regeneron-announce-that-dupilumab-has-received-fda-breakthrough-therapy-designation-in-atopic-dermatitis-2 July 7, 2017
http://medimmune.com/about-us/media/medimmune-and-regeneron-enter-into-licensing-agreement-for-the-development-of-antibody-drug-conjugates-to-treat-cancer-05042016.html June 6, 2016
http://intelliatx.com/category/news/page/3 March 3, 2017
http://arthritis.allaboutyourhealth.info/infectious-arthritis/regeneron-and-adicet-bio-announce-strategic-collaboration-to-discover-and-develop-next-generation-engineered.html September 9, 2016
http://mediaroom.sanofi.com/sanofi-sanofi-et-regeneron-annoncent-les-resultats-positifs-dune-etude-de-phase-2b-du-dupilumab-chez-les-patients-souffrant-dasthme-modere-a-severe-2 May 5, 2017
http://societyforscience.org/content/press-room/regeneron September 9, 2016
http://marketwatchedz.tk/story/regeneron-details-royalty-agreement-with-novartis-for-canakinumab-acz885-2017-06-22 July 7, 2017
http://marketwatchedz.tk/story/regeneron-recognized-on-the-civic-50-list-of-the-most-community-minded-companies-in-the-united-states-2017-06-21 July 7, 2017
http://marketwatchedz.tk/story/regeneron-announces-angptl3evinacumab-publication-in-new-england-journal-of-medicine-and-positive-phase-2-data-in-people-with-hofh-2017-05-24 July 7, 2017
http://marketwatchedz.tk/story/regeneron-and-inovio-enter-immuno-oncology-clinical-study-agreement-for-glioblastoma-combination-therapy-2017-05-08 July 7, 2017
http://marketwatchedz.tk/story/inovio-regeneron-enter-immuno-oncology-clinical-study-agreement-for-glioblastoma-combination-therapy-2017-05-08 July 7, 2017
http://biotechstocks.com/tag/biotech-stocks/page/2 June 6, 2016
http://biotechstocks.com/category/biotech-stocks-news/page/2 June 6, 2016
http://biotechstocks.com/tag/best-biotech-stocks/page/2 June 6, 2016
http://biotechstocks.com/tag/biotech-industry-news/page/2 June 6, 2016
http://intelliatx.com/category/news May 5, 2016
http://prnewswire.com/news-releases/regeneron-ceo-leonard-schleifer-and-cso-george-yancopoulos-named-ey-2016-national-life-sciences-entrepreneurs-of-the-year-300366403.html July 7, 2017
http://intelliatx.com/category/news/page/2 January 1, 2017
http://buzzstake.com/regeneron-and-intellia-therapeutics-announce-collaboration-to-discover-and-develop-crisprcas-therapeutics April 4, 2016
http://cmarketwatchez.tk/story/regeneron-announces-angptl3evinacumab-publication-in-new-england-journal-of-medicine-and-positive-phase-2-data-in-people-with-hofh-2017-05-24 May 5, 2017
http://cmarketwatchez.tk/story/regeneron-and-inovio-enter-immuno-oncology-clinical-study-agreement-for-glioblastoma-combination-therapy-2017-05-08 May 5, 2017
http://cmarketwatchez.tk/story/inovio-regeneron-enter-immuno-oncology-clinical-study-agreement-for-glioblastoma-combination-therapy-2017-05-08 May 5, 2017
http://ariva.de/news/regeneron-and-teva-announce-global-collaboration-to-develop-5884164 December 12, 2016
http://tevapharm.com/news/teva_and_regeneron_announce_global_collaboration_to_develop_and_commercialize_fasinumab_an_investigational_ngf_antibody_for_chronic_pain_09_16.aspx October 10, 2016
http://intelliatx.com/regeneron-intellia-therapeutics-announce-collaboration-discover-develop-crisprcas-therapeutics May 5, 2016
http://biotechstocks.com/regn-selected-by-society-for-science June 6, 2016
http://wallstreet-online.de/nachricht/8243085-sanofi-and-regeneron-announce-sarilumab-biologics-license-application-accepted-for-review-by-us-fda December 12, 2016
http://asianhhm.com/pressreleases/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union September 9, 2015
http://news.sanofigenzyme.com/print/node/3417 February 2, 2017
http://life-sciences-france.com/product/praluent-sanofi-euronext-san-nyse-sny-group-since-2001-25136.html June 6, 2016
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-announce-first-approval-kevzaratm-sarilumab-treatment-moderately- February 2, 2017
http://fiercepharma.com/marketing/sanofi-and-regeneron-announce-topline-results-of-phase-3-monotherapy-study-demonstrating November 11, 2016
http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-et-regeneron-annoncent-lapprobation-au-japon-de-praluent-alirocumab-dans-le-traitement-de-lhypercholesterolemie November 11, 2016
http://medindia.net/health-press-release/regeneron-presents-positive-interim-data-from-phase-2-proof-of-concept-study-of-evinacumab-in-patients-with-homozygous-familial--289572-1.htm November 11, 2016
http://euroinvestor.fr/actualites/2017/02/08/sanofi-la-cour-dappel-accorde-la-supension-de-linjonction-permanente-visant-praluent-alirocumab-pendant-la-duree-de-la-procedure-dappel/13528975 February 2, 2017
http://life-sciences-france.com/news/sanofi-regeneron-receive-complete-euronext-san-nyse-sny-2001-109248.html November 11, 2016
http://life-sciences-france.com/product/sarilumab-sanofi-euronext-san-nyse-sny-group-since-2001-25591.html June 6, 2016
http://pharmalive.com/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union May 5, 2016
http://pharmalive.com/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union/ September 9, 2015
http://news.genzyme.com/print/node/3268 June 6, 2016
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-topline-results-phase-3-monotherapy-study-demonstrating- June 6, 2016
http://biotechstocks.com/tag/biotech-stock-news June 6, 2016
http://biotechstocks.com/regn-presents-positive-interim-data June 6, 2016
http://biotechstocks.com/tag/best-biotech-stocks June 6, 2016
http://biotechstocks.com/category/biotech-stocks-news June 6, 2016
http://biotechstocks.com/tag/biotech-industry-news June 6, 2016
http://prnewswire.com/news-releases/regeneron-and-sanofi-announce-praluent-alirocumab-marketing-authorization-application-has-been-accepted-for-review-by-ema-300018715.html October 10, 2016
http://asianhhm.com/prnews/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union September 9, 2015
http://news.genzyme.com/press-release/sanofi-and-regeneron-present-results-phase-3-monarch-study-investigational-sarilumab-a February 2, 2017
http://fiercebiotech.com/biotech/regeneron-and-sanofi-announce-sarilumab-biologics-license-application-accepted-for-review December 12, 2016
http://prnewswire.com/news-releases/sanofi-and-regeneron-announce-unitedhealth-group-selects-praluent-alirocumab-injection-for-preferred-access-300191648.html October 10, 2016
http://research-tree.com/newsfeed/newsrelease/60500 March 3, 2016
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-present-results-phase-3-monarch-study-investigational-sarilumab-a February 2, 2017
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-receive-complete-response-letter-fda-sarilumab-investigational-tr February 2, 2017
http://news.sanofigenzyme.com/print/node/3438 February 2, 2017
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-first-approval-kevzaratm-sarilumab-treatment-moderately- February 2, 2017
http://drugs.com/clinical_trials/sanofi-regeneron-report-positive-results-sarilumab-16345.html October 10, 2016
http://prnewswire.com/news-releases/eylea-aflibercept-injection-recommended-for-approval-for-the-treatment-of-visual-impairment-due-to-diabetic-macular-edema-in-the-european-union-264880011.html May 5, 2015
http://bio-medicine.org/medicine-technology-1/sanofi-and-regeneron-announce-patient-enrollment-in-two-phase-3-trials-with-sarilumab-in-rheumatoid-arthritis--28ra-29-32962-1 June 6, 2017
http://macularhope.org/regeneron-highlights-eylea-aflibercept-injection-data-presented-american-academy-ophthalmology-annual-meeting May 5, 2016
http://mediaroom.sanofi.com/sanofi-sanofi-et-regeneron-vont-presenter-des-donnees-cliniques-sur-lalirocumab-aux-63emes-seances-scientifiques-annuelles-de-lamerican-college-of-cardiology-2 August 8, 2017
http://mediaroom.sanofi.com/sanofi-sanofi-and-regeneron-to-present-alirocumab-clinical-data-at-american-college-of-cardiology-63rd-annual-scientific-session July 7, 2017
http://frenchbiobeach.com/join-our-email-list/page/11 April 4, 2016
http://prnewswire.com/news-releases/sanofi-and-regeneron-report-positive-top-line-results-with-alirocumab-from-first-phase-3-study-of-a-pcsk9-inhibitor-for-ldl-cholesterol-reduction-227948681.html April 4, 2015
http://biospace.com/news/sanofi-france-and-regeneron-pharmaceuticals-inc/296756 January 1, 2015
http://biospace.com/news/regeneron-pharmaceuticals-inc-and-bayer-healthcare/304920 January 1, 2015
http://biospace.com/news/regeneron-pharmaceuticals-inc-fda-accepts-sbla-for/318964/source=morenews January 1, 2015
http://thestreet.com/story/12021691/1/eylea-aflibercept-injection-approved-in-europe-for-the-treatment-of-visual-impairment-due-to-macular-edema-secondary-to-central-retinal-vein-occlusion.html October 10, 2016
http://thestreet.com/story/12040321/1/regeneron-to-present-phase-3-data-for-eylea-aflibercept-injection-in-diabetic-macular-edema-at-upcoming-retina-society-meeting.html May 5, 2016
http://newsroom.regeneron.com/releasedetail.cfm April 4, 2015
http://prnewswire.com/news-releases/regeneron-highlights-eylea-aflibercept-injection-data-to-be-presented-at-american-academy-of-ophthalmology-annual-meeting-231629281.html January 1, 2015
http://thestreet.com/story/11999721/1/regeneron-and-bayer-report-positive-one-year-results-from-two-phase-3-trials-of-eylea-aflibercept-injection-for-the-treatment-of-diabetic-macular-edema.html October 10, 2016
http://thestreet.com/story/12466590/3/bayer-healthcare-and-regeneron-announce-regulatory-submission-of-eylea-aflibercept-injection-for-the-treatment-of-diabetic-macular-edema-in-japan.html May 5, 2015
http://bio-medicine.org/medicine-technology-1/sanofi-and-regeneron-report-positive-results-with-sarilumab-in-first-phase-3-rheumatoid-arthritis-registration-trial-37118-1 March 3, 2016
http://frenchbiobeach.com/category/biotech-news/page/4 April 4, 2016
http://investor.regeneron.com/releasedetail.cfm May 5, 2015
http://prnewswire.com/news-releases/two-year-results-from-phase-3-vista-trial-of-eylea-aflibercept-injection-for-the-treatment-of-diabetic-macular-edema-show-sustained-improvement-in-vision-244696531.html February 2, 2015
http://biospace.com/news_story.aspx April 4, 2015
http://thestreet.com/story/12160165/3/sanofi-regeneron-to-collaborate-with-american-college-of-cardiology-for-pcsk9-inhibitor-clinical-program.html January 1, 2015
http://biospace.com/news/sanofi-france-and-regeneron-pharmaceuticals-inc/319187 January 1, 2015
http://drugs.com/clinical_trials/sanofi-regeneron-cuts-ldl-phase-iii-study-16197.html October 10, 2016
http://prnewswire.com/news-releases/sanofi-and-regeneron-to-present-alirocumab-clinical-data-at-the-american-college-of-cardiologys-63rd-annual-scientific-session-252586521.html May 5, 2015
http://frenchbiobeach.com/2013/11/23/sanofi-and-regeneron-report-positive-results-with-sarilumab-in-first-phase-3-rheumatoid-arthritis-registration-trial April 4, 2016
http://drugs.com/clinical_trials/vegf-trap-eye-shows-positive-results-phase-2-study-patients-diabetic-macular-edema-8883.html April 4, 2015
http://drugs.com/clinical_trials/regeneron-announces-positive-results-exploratory-proof-concept-study-rilonacept-chronic-active-gout-1904.html January 1, 2015
http://bio-medicine.org/medicine-news-1/regeneron-announces-presentation-at-the-21st-annual-piper-jaffray-healthcare-conference-62019-1 April 4, 2014
http://bio-medicine.org/medicine-technology-1/phase-3-trial-of-aflibercept-in-metastatic-pancreatic-cancer-discontinued-4975-5 February 2, 2015
http://bio-medicine.org/medicine-news-1/regeneron-announces-september-2009-investment-conference-presentations-56871-1 May 5, 2017
http://drugs.com/news/regeneron-closes-312-million-common-stock-sale-connection-sanofi-aventis-collaboration-7451.html April 4, 2015
http://massagemag.com/regeneron-announces-presentation-at-needham-seventh-annual-biotechnology-and-medical-technology-conference-957 September 9, 2017
http://bio-medicine.org/medicine-technology-1/phase-3-trial-of-aflibercept-in-metastatic-pancreatic-cancer-discontinued-4975-1 August 8, 2017
http://newsroom.regeneron.com/releasedetail.cfm April 4, 2015
http://biospace.com/news/regeneron-pharmaceuticals-inc-jobs-sanofi-aventis/162454 January 1, 2015
http://drugs.com/clinical_trials/sanofi-aventis-regeneron-announce-results-phase-2-study-aflibercept-vegf-trap-advanced-ovarian-7528.html January 1, 2015
http://drugs.com/clinical_trials/regeneron-bayer-healthcare-announce-vegf-trap-eye-achieved-durable-improvement-vision-over-52-weeks-5314.html February 2, 2015
http://bio-medicine.org/medicine-technology-1/regeneron-announces-presentation-at-the-deutsche-bank-2009-biotech-boston-confab-6892-1 January 1, 2015
http://medindia.net/health-press-release/regeneron-announces-participation-in-a-panel-discussion-at-rbc-capital-markets-healthcare-conference-62072-1.htm July 7, 2017

Please log in to uncover the email addresses, access the 152 results for regeneron.com, filters and more.

Create a free account

Already have an account? Sign in

More information about regeneron.com

Industry: Science

Language of the website: English

Main technologies used:

Find email addresses from any website

Search contact information of any website in one click.

When you visit a website, click on the icon to find the email addresses related to the website.